ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and sufficiency of disclosure, explains patent attorney Noah K. Tilton.

Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to warrant ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

President Donald Trump has nominated Dilworth Paxson partner John A. Squires to serve as the director of the US Patent and Trademark Office and under secretary of Commerce for intellectual property, ...

The world received the first FDA-approved CRISPR therapy in December 2023. Image credit: Shutterstock / Panuwach. ElevateBio has partnered with Amazon Web Services (AWS) to expedite the discovery and ...

For the 12th consecutive year, the University of South Florida is one of the nation's top 20 public research universities for producing new U.S. utility patents, according to a new ranking released ...

The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun ...

Moderna was dealt a significant blow in the patent battle over who owns the Covid-19 vaccine last week. In the U.S., the Cambridge drug and vaccine maker hit a roadblock when the Patent Trial and ...